Safety and utility of CardioMEMS device for remote pulmonary artery monitoring in paediatric Fontan patients: a case series

Abstract Background Patients with single ventricle congenital heart disease who undergo total cavo-pulmonary anastomosis (Fontan surgery) suffer from elevated pulmonary artery pressure (PAP), which leads to multiple adverse sequelae. Traditionally, the Fontan pressures are assessed via invasive haem...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal : case reports 2023-09, Vol.7 (9)
Main Authors: Bhat, Deepti P, Graziano, Joseph N, Garn, Byron J, Franklin, Wayne J
Format: Article
Language:English
Subjects:
Case Series
Catheterization
Congenital heart disease
Genetic disorders
Heart
Heart diseases
Patient monitoring equipment
Pulmonary hypertension
Rivaroxaban
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Patients with single ventricle congenital heart disease who undergo total cavo-pulmonary anastomosis (Fontan surgery) suffer from elevated pulmonary artery pressure (PAP), which leads to multiple adverse sequelae. Traditionally, the Fontan pressures are assessed via invasive haemodynamic catheterization that exposes these medically fragile patients to the risks of vascular injury and anaesthesia. While the CardioMEM remote PAP monitor has been extensively used in adults with heart failure, the safety of this device has not been established in children. Case summary We report safety and utility of this device in eight paediatric Fontan patients. Our patients ranged from 9 to 18 years of age. There were no reported complications related to the implantation of the CardioMEMS device in our population. Discussion This is the first case series of safety of CardioMEMS device in paediatric Fontan Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation patients. Our experience indicates that the device may be safely utilized for the management of Fontan-related complications in this vulnerable population.
ISSN:2514-2119
2514-2119
DOI:10.1093/ehjcr/ytad422